UiPath Shares Drop Amid Weak Fiscal 2026 Outlook
UiPath (PATH, Financials) shares fell 13.8% to $10.19 as of 2:05 p.m. GMT-4 on Thursday, extending losses after the company issued cautious guidance for fiscal 2026, missing analysts expectations.
Below analysts' projections of $1.58 billion, the supplier of automation software anticipated fiscal 2026 income between $1.525 billion and $1.53 billion. Comparatively to $1.66 billion at the end of fiscal 2025, which represents a 14% year-over-year growth, the business estimates Annual Recurring Revenue for the fiscal year to be between $1.816 billion and $1.821 billion.UiPath stated income of $424 million for the fourth quarter, up 5% year over year. With net new ARR of $60 million added and adjusted profits per share of $0.26, the firm exceeded forecasts by $0.07.Over the previous two weeks, CEO Daniel Dines said, "significant increase in macroeconomic volatility" has harmed consumer budgets. He also underlined as a further difficulty changes in foreign exchange. Dines said UiPath is keeping its agentic platform first priority and is approaching its fiscal 2026 projection sensibly.To further expand AI solutions, the firm recently revealed the purchase of Peak, a Manchester, UK-based AI-native startup. Peak's AI apps will be included into UiPath's platform in order to improve industry-specific solutions.
This article first appeared on GuruFocus.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Wall Street on Edge: Inflation Spike, $58B Debt Test, and Trade Turmoil Collide
Wall Street is holding its breath as two market-moving forces line up: inflation and debt. Investors are watching closely as the U.S. and China restart trade talks in London, aiming to ease tensions and avoid another round of tariff escalations. Meanwhile, a $58 billion Treasury auction could test demand for U.S. debt at a time when long-end yields hover near 5%a level many thought would spark broader market reactions. BMO's Ian Lyngen calls this week's combo of May CPI and Treasury supply a tradable event, with core inflation expected to accelerate to 2.9% year-over-yearthe first uptick of the year. The S&P 500 (SPY) sits roughly 2% from its February peak, but volatility could return fast depending on how these numbers land. Warning! GuruFocus has detected 5 Warning Sign with META. Despite the rebound from April's tariff-driven slide, institutional investors have yet to jump back into equities in full force. Deutsche Bank notes that institutional positioning has been this low less than a quarter of the time since 2010. JPMorgan and Barclays, however, suggest the tide could be turning, with more big money managers set to ramp up equity exposure. That shift hasn't shown up yetBank of America's clients were net sellers last week, with institutions pulling out while hedge funds and retail buyers stepped in. Strategist Jill Carey Hall thinks the market may have already priced in much of the deglobalization risk, but not the potential upside from underappreciated tax policy tailwinds. On the corporate front, action is heating up. Tesla (NASDAQ:TSLA) isn't grabbing headlines today, but its peers are moving fast. Meta's (NASDAQ:META) CEO Mark Zuckerberg is going all-in on artificial general intelligence, quietly assembling a powerhouse team to build out the next big wave in AI. Boeing (NYSE:BA) just secured its biggest monthly order tally in over a yearmuch of it inked during President Trump's trip to the Middle East. Cisco (NASDAQ:CSCO) is rolling out new AI-powered upgrades across its networking portfolio to stay competitive in the enterprise race. Taiwan Semiconductor (NYSE:TSM) posted a 40% revenue surge in May as chipmakers rushed to build inventory ahead of potential trade roadblocks. Not everything was rosyMcDonald's (NYSE:MCD) was slapped with a rare sell rating from Redburn Atlantic, and Citigroup (NYSE:C) is preparing to book hundreds of millions more in loan loss provisions, signaling early cracks in consumer credit health. This article first appeared on GuruFocus.
Los Angeles Times
35 minutes ago
- Los Angeles Times
States sue to block the sale of genetic data collected by DNA testing company 23andMe
Dozens of states have filed a joint lawsuit against the bankrupt DNA-testing company 23andMe to block the company's sale of its customers' genetic data without explicit consent. The suit, filed this week in U.S. Bankruptcy Court in the Eastern District of Missouri, comes months after 23andMe began a court-supervised sale process of its assets. The South San Francisco-based venture was once valued at $6 billion and has collected DNA samples from more than 15 million customers. The company's bankruptcy has raised questions over privacy standards for genetic data, which experts say is uniquely sensitive, immutable and irreplaceable if stolen. Twenty-seven states and the District of Columbia filed the lawsuit, arguing that 23andMe customers have an inherent right to their own genetic information. 'This isn't just data — it's your DNA,' said Oregon Atty. Gen. Dan Rayfield in a statement. 'It's personal, permanent, and deeply private. People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest bidder.' 23andMe announced in May that it would be sold to New York-based drug maker Regeneron Pharmaceuticals, which had agreed to comply with 23andMe's existing privacy policy. However, a competing offer from nonprofit TTAM Research Institute led the bankruptcy judge to reopen the auction last week. TTAM is run by 23andMe co-founder Anne Wojcicki, who has made several failed attempts to take the company private. In a statement, a 23andMe spokesperson said the lawsuit's claims 'are without merit' and that the sale of genetic data does not violate privacy regulations. 'Customers will continue to have the same rights and protections in the hands of the winning bidder,' the spokesperson said. 23andMe customers have the right to delete their genetic information from the company's database at any time, as outlined in the Genetic Information Privacy Act and the California Consumer Privacy Act. During a testimony in Washington earlier this week, 23andMe interim Chief Executive Joseph Selsavage said that 1.9 million customers have requested their data be deleted since the company's bankruptcy filing in March. Sara Geoghegan, senior counsel at the Electronic Privacy Information Center, said that 23andMe's privacy policy was subject to change and not adequate to protect customers' data. In an interview in March, she stressed the sensitivity of genetic data. 'I would be very concerned if I had given a swab to 23andMe,' she said. 'There is little we can do to control what happens to it.'
Miami Herald
39 minutes ago
- Miami Herald
ID.Buzz Could Get Compact Sibling As VW Evaluates New EV Plans
The Volkswagen is one of the most cheerful new family vehicles you can buy, but its starting price of $59,995 limits its appeal. That's still far more expensive than conventional gas or hybrid minivans like the Chrysler Pacifica. However, it looks like a smaller, cheaper sibling could be on the way, based on a new report by Autocar. The report suggests that the new VW would replace the Touran, an MPV that has never been sold in the United States, given our market's preference for SUVs. Currently being internally reviewed by Volkswagen, the potential Touran replacement could draw inspiration from one of the brand's most exciting concepts. The Budd-E was the first VW model to be based on the MEB modular platform that now underpins models like the ID.4, ID.7 and The electric minivan concept still looks ultra-modern today, with its wraparound windshield, two-tone body, and bold face with sleek lighting. It's this concept that could inspire the Touran replacement, but this is just one of several older MPV concepts VW is reviewing. The minimal overhangs and flat floor will maximize interior space but keep the proportions tight, which is exactly why this type of vehicle excels. According to insiders, new sliding door and seat designs are being considered to make this vehicle as versatile as possible. Powering the Touran replacement could be a choice of single or dual electric motors. To keep the price low enough, an output of around 200 to 250 hp seems reasonable, given that the larger manages between 282 and 335 hp. The and ID.4 are rear-wheel drive as standard, but its smaller sibling may rely on front-wheel drive as standard. Battery capacities of 60 to 80 kWh have been suggested as likely. EVs of this size would be expected to have a range of at least 240 miles or so to be competitive. At this point, it seems unlikely that a smaller version of the would be sold here. Such a vehicle would clash with the ID.4 in terms of price - the priciest ID.4 starts at just below the price of the Besides this, few Americans choose SUVs over minivans or MPVs. The smaller and cheaper is expected to be launched by 2027 at the earliest, assuming Volkswagen does decide to put it into production. If it has the same nostalgic styling and clever versatility of the but at a lower price, it'll be one of VW's top EVs. Copyright 2025 The Arena Group, Inc. All Rights Reserved.
